Mechanism of Action: Serotonin 3 Receptor Antagonists
✉ Email this page to a colleague
Drugs with Mechanism of Action: Serotonin 3 Receptor Antagonists
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heron Theraps Inc | SUSTOL | granisetron | INJECTABLE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | RX | Yes | Yes | 10,357,570 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Heron Theraps Inc | SUSTOL | granisetron | INJECTABLE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | RX | Yes | Yes | 8,252,305 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Heron Theraps Inc | SUSTOL | granisetron | INJECTABLE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | RX | Yes | Yes | 9,913,910 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Heron Theraps Inc | SUSTOL | granisetron | INJECTABLE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | RX | Yes | Yes | 8,715,710 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Heron Theraps Inc | SUSTOL | granisetron | INJECTABLE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | RX | Yes | Yes | 8,252,304 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Cumberland | SANCUSO | granisetron | FILM, EXTENDED RELEASE;TRANSDERMAL | 022198-001 | Sep 12, 2008 | RX | Yes | Yes | 7,608,282 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Avyxa Holdings | POSFREA | palonosetron hydrochloride | SOLUTION;INTRAVENOUS | 203050-001 | Mar 1, 2016 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
